The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Wed., Feb. 26, 6:09 PM

Slide #88. Zealand Pharma A/S Valeritas Holdings, Inc.

Acquirer: Zealand Pharma A/S
Acquiree: Valeritas Holdings, Inc. (NASDAQ:VLRX)
Details: Zealand Pharma A/S (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces a bid to acquire substantially all assets from Valeritas Holdings, Inc. (NASDAQ: VLRX) for a total cash consideration of $23 million and the assumption of certain liabilities related to the ongoing business, pursuant to the terms of the "stalking horse" asset purchase agreement entered into with Valeritas (as described below).

Open the VLRX Page at The Online Investor »

Company Name: 
Valeritas Holdings Inc
Medical Instruments & Supplies

Open the VLRX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.